Using stated preference methods to design gender-affirming long-acting PrEP programs for transgender and nonbinary adults.

ABSTRACT: Integrating gender-affirming care with biomedical HIV prevention could help address the disproportionate HIV risk experienced by transgender and nonbinary (trans) adults. This discrete choice experiment assesses and identifies the most important programming factors influencing the decisions of trans adults to use injectable long-acting HIV pre-exposure prophylaxes (LA-PrEP). From March to April 2023 n = 366 trans adults in Washington state chose between four different choice profiles that presented hypothetical programs (each comprised of 5 attributes with 4 levels). We analyzed ranked choice responses using a mixed rank-ordered logit model for main effects. Respondents preferred to receive LA-PrEP from a gender-affirming care provider and a co-prescription for both oral and injectable hor

SUBMITTER: Restar A 

PROVIDER: S-EPMC11461737 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature